Decibel Therapeutics, Inc. Profile Avatar - Palmy Investing

Decibel Therapeutics, Inc.

Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for …

Biotechnology
US, Boston [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Decibel Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Decibel Therapeutics, Inc. can't present revenue by segment

End of DBTX's Analysis
CIK: 1656536 CUSIP: 24343R106 ISIN: US24343R1068 LEI: - UEI: -
Secondary Listings
DBTX has no secondary listings inside our databases.